Zydus Group is exploring the sale of its clinical research business, Cliantha Research Ltd, in a deal that could potentially fetch more than $200 million, three people familiar with the development said. The Zydus family is seeking a price of between $200 million and $250 million for Cliantha Research, the people ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.